Q32 Bio Inc. (FIXX) Operating cash flow 2017–2025
Q32 Bio Inc. (FIXX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$33.5MFY2025 · since FY2017: $6.5M → -$33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.5M | +50.5% |
| FY2024 | -$67.7M | -262.6% |
| FY2023 | -$18.7M | +83.6% |
| FY2022 | -$113.7M | -3.6% |
| FY2021 | -$109.8M | -16.3% |
| FY2020 | -$94.3M | -3.3% |
| FY2019 | -$91.4M | -114.6% |
| FY2018 | -$42.6M | -756.9% |
| FY2017 | $6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice